# Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)

> **NCT01458613** · — · WITHDRAWN · sponsor: **CENTOGENE GmbH Rostock**

## Conditions studied

- Lysosomal Storage Disease
- Lung Diseases
- Obstructive Sleep Apnoea
- Macroglossia
- Eye Abnormalities

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01458613
- **Lead sponsor:** CENTOGENE GmbH Rostock
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-08-20
- **Primary completion:** 2021-02-28
- **Final completion:** 2021-02-28
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Transition into BioMetabol
- **Last updated:** 2023-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01458613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01458613, "Biomarker for Maroteaux-Lamy Disease (BioMaroteaux)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01458613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*